STI
31
19
DE
36
-2
FDX
54
14
SHW
70
2
HSY
43
3
AIZ
78
2
SYF
93
-2
VNO
60
8
SIG
47
-2
CHD
48
-3
JCI
61
-2
DRI
56
2
SWK
56
-6
GIS
29
3
PSA
58
5
IFF
53
2
LEN
52
2
NSC
64
2
NRG
50
-2
MPC
47
3
STI
31
19
DE
36
-2
FDX
54
14
SHW
70
2
HSY
43
3
AIZ
78
2
SYF
93
-2
VNO
60
8
SIG
47
-2
CHD
48
-3
JCI
61
-2
DRI
56
2
SWK
56
-6
GIS
29
3
PSA
58
5
IFF
53
2
LEN
52
2
NSC
64
2
NRG
50
-2
MPC
47
3
Financhill
Back

Genmab AS Stock Predictions

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
32

GMAB
Genmab AS

Last Price:
21.30
Seasonality Move:
3.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Genmab AS Stock Forecast

  • Over the next 52 weeks, Genmab AS has on average historically risen by 24.1% based on the past 11 years of stock performance.
  • Genmab AS has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
  • Is Genmab AS Stock Undervalued?
    The current Genmab AS [GMAB] share price is $21.67. The Score for GMAB is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Genmab AS Stock Go Up Next Year?

  • Over the next 52 weeks, Genmab AS has on average historically risen by 24.1% based on the past 11 years of stock performance.

Genmab AS Stock Rating

Sell
32
Genmab AS (GMAB) is a Sell

Is Genmab AS overpriced?

  • Genmab AS has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%

Genmab AS Stock Price History

Is GMAB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com

52-Week Data

52-Week High:
32.89
52-Week Low:
21.90

Prediction Charts

Market Cap:
13.76B
Price in USD:
21.67
Volume:
2.58M
Beta:
0.71

Technical Analysis

SMA50:
24.08
SMA100:
25.51
SMA200:
27.13
52-Wk Change:
-32.6%

Stock Predictions

  • Is Genmab AS stock public?
    Yes, Genmab AS is a publicly traded company.
  • What is the Genmab AS stock quote today?
    The Genmab AS stock price is 21.67 USD today.
  • How to buy Genmab AS stock online?
    You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-25 22.74 23.12 23.30 22.73
Oct-28 23.08 23.14 23.21 22.95
Oct-29 23.05 23.12 23.15 22.87
Oct-30 22.69 22.57 22.82 22.56
Oct-31 22.36 22.32 22.40 22.22
Nov-1 22.61 22.56 22.63 22.53
Nov-4 22.69 22.78 22.89 22.65
Nov-5 22.56 22.75 22.84 22.18
Nov-6 22.20 22.33 22.76 21.90
Nov-7 22.64 23.11 23.19 22.64
Nov-8 22.85 23.08 23.18 22.80
Nov-11 23.18 23.20 23.47 22.95
Nov-12 22.90 22.47 22.94 22.41
Nov-13 21.94 21.67 22.20 21.59

Genmab AS Earnings

Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Genmab AS Forecast Revenue Growth

Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.29 per share.

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.